Merrimack Pharmaceuticals Inc. (MACK) Slipped -9.93% or -1.15 To Price $10.43 On Monday


Merrimack Pharmaceuticals Inc. (MACK) slipped -9.93% or -1.15 to $10.43. It is nearly 100000 shares traded, which is 82.08% compare to the average total volume 121838. The market cap of MACK is $139.06 million. The year to date change is 8.73%. The 52 week price range is from $9.68 to $39.9. Price of MACK have changed 1.85% during last week. It have changed 15.22% over last month, 14.09% over last 3 months, -15.54% over last 6 months and -63.24% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MACK is 10.84. It is 3.93% above current price. The 200-day Moving Averages for MACK is 12.65. It is 21.28% above current price. The 52-week High is 39.9. It is 282.55% from the current price. The 52-week Low is 9.68. It is -7.19% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of MACK is 11.65 on 2018-02-15. Short % to float is 33.88%. There are some statistics of MACK. It is has market cap $139.06 million. The share outstanding is 13.33 million. The average volume is 121838. The revenue is 61.24M. The gross profit is 57.92M. The percent of top 15 Institution holding is 34.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MACK is -786.00%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MACK is 286.18%.


Tags:

Share this post